Recent events

Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.

Everything the market-wide feed shows by default: the rare events, plus management changes, restructurings, impairments, new debt and material agreements.

Date Company Event Filing
SeaStar Medical Holding Corp ICU Officer or director change Item 5.02 Form 8-K
Sharplink, Inc. SBET Material agreement signed Item 1.01 Form 8-K
Silicon Valley Acquisition Corp. SVAQ Material agreement signed Item 1.01 Form 8-K
Sky Harbour Group Corp SKYH Officer or director change Item 5.02 Form 8-K
Stellar V Capital Corp. (Cayman Islands) SVCC New debt or obligation Item 2.03 Form 8-K
Sunbelt Rentals Holdings, Inc. SUNB Annual report filed FY to 2026-04-30 Form 10-K
TALPHERA, INC. TLPH Officer or director change Item 5.02 Form 8-K
TEAM INC TISI Officer or director change Item 5.02 Form 8-K
TON Strategy Co TONX Delisting notice Item 3.01 Form 8-K
Tango Therapeutics, Inc. TNGX Officer or director change Item 5.02 Form 8-K
Teucrium Commodity Trust BTCK Auditor changed Item 4.01 Form 8-K
Theravance Biopharma, Inc. TBPH Officer or director change Item 5.02 Form 8-K
UMH PROPERTIES, INC. UMH Officer or director change Item 5.02 Form 8-K
UPWORK, INC UPWK Material agreement signed Item 1.01 Form 8-K
UPWORK, INC UPWK New debt or obligation Item 2.03 Form 8-K
UroGen Pharma Ltd. URGN Shareholder rights changed Item 3.03 Form 8-K
UroGen Pharma Ltd. URGN Officer or director change Item 5.02 Form 8-K
Vaxcyte, Inc. PCVX Officer or director change Item 5.02 Form 8-K
WORTHINGTON ENTERPRISES, INC. WOR Officer or director change Item 5.02 Form 8-K
Wendy's Co WEN Officer or director change Item 5.02 Form 8-K
AGILYSYS INC AGYS Officer or director change Item 5.02 Form 8-K
ALIGN TECHNOLOGY INC ALGN Officer or director change Item 5.02 Form 8-K
ANAPTYSBIO, INC ANAB Material agreement signed Item 1.01 Form 8-K
ARES CAPITAL CORP ARCC Material agreement signed Item 1.01 Form 8-K
ARES CAPITAL CORP ARCC New debt or obligation Item 2.03 Form 8-K
ARVINAS, INC. ARVN Officer or director change Item 5.02 Form 8-K
AXT INC AXTI Officer or director change Item 5.02 Form 8-K
Adaptive Biotechnologies Corp ADPT Material agreement signed Item 1.01 Form 8-K
Adaptive Biotechnologies Corp ADPT Material agreement terminated Item 1.02 Form 8-K
Adaptive Biotechnologies Corp ADPT New debt or obligation Item 2.03 Form 8-K
AeroVironment Inc AVAV Accounts can no longer be relied on Item 4.02 Form 8-K
AeroVironment Inc AVAV Officer or director change Item 5.02 Form 8-K
Algorhythm Holdings, Inc. RIME Material agreement signed Item 1.01 Form 8-K
Apogee Therapeutics, Inc. APGE Material agreement signed Item 1.01 Form 8-K
Apogee Therapeutics, Inc. APGE Material agreement signed Item 1.01 Form 8-K
Arcosa, Inc. ACA Material agreement signed Item 1.01 Form 8-K
BEST BUY CO INC BBY Officer or director change Item 5.02 Form 8-K
BITGO HOLDINGS, INC. BTGO Officer or director change Item 5.02 Form 8-K
Bloom Energy Corp BE Officer or director change Item 5.02 Form 8-K
Blue Owl Technology Finance Corp. OTF Material agreement signed Item 1.01 Form 8-K

Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.